While the WHO points out that NB.1.8.1 is “growing rapidly compared to co-circulating variants,” the agency also notes that there’s no evidence that the variant will cause more health risks compared ...

In some cases, "symptoms can escalate to more severe respiratory distress," infectious disease expert Dr. Tyler Evans told Newsweek.